Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European journal of medicinal chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2011.09.056PMID 22071255PMCID PMC3357065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

  2011cited by this paper
• Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter

  2011cited by this paper
• Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.

  2011cited by this paper
• Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine*

  2010cited by this paper
• A Medicinal Chemist’s Guide to Molecular Interactions

  2010cited by this paper
• GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complex

  2010cited by this paper
• Recipes for the Selection of Experimental Protein Conformations for Virtual Screening

  2010cited by this paper
• Evidence for noncompetitive modulation of substrate‐induced serotonin release

  2010cited by this paper
• The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter

  2010cited by this paper
• The flexible pocketome engine for structural chemogenomics.

  2009cited by this paper
• Structure and localisation of drug binding sites on neurotransmitter transporters

  2009cited by this paper
• Antidepressant specificity of serotonin transporter suggested by three LeuT–SSRI structures

  2009influential reference
• Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking.

  2009influential reference
• Binding and Orientation of Tricyclic Antidepressants within the Central Substrate Site of the Human Serotonin Transporter*

  2009cited by this paper
• Analysis of full and partial agonists binding to β2‐adrenergic receptor suggests a role of transmembrane helix V in agonist‐specific conformational changes

  2009cited by this paper
• Structural determinants of species‐selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies

  2009cited by this paper
• Fluoxetine (Prozac) Binding to Serotonin Transporter Is Modulated by Chloride and Conformational Changes

  2009cited by this paper
• Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin Transporter*

  2009cited by this paper
• Location of the Antidepressant Binding Site in the Serotonin Transporter

  2009cited by this paper
• Protein-Ligand Docking against Non-Native Protein Conformers

  2008cited by this paper
• Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.

  2008cited by this paper
• Improving database enrichment through ensemble docking

  2008cited by this paper
• Comparative Molecular Field Analysis Using Selectivity Fields Reveals Residues in the Third Transmembrane Helix of the Serotonin Transporter Associated with Substrate and Antagonist Recognition

  2008cited by this paper
• A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation

  2008influential reference
• Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.

  2008cited by this paper
• Flexible ligand docking to multiple receptor conformations: a practical alternative.

  2008cited by this paper
• Ibogaine, a Noncompetitive Inhibitor of Serotonin Transport, Acts by Stabilizing the Cytoplasm-facing State of the Transporter*

  2007cited by this paper
• Antidepressant binding site in a bacterial homologue of neurotransmitter transporters

  2007influential reference
• Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.

  2007cited by this paper
• LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake

  2007influential reference
• The Cytoplasmic Substrate Permeation Pathway of Serotonin Transporter*

  2006cited by this paper
• Novel procedure for modeling ligand/receptor induced fit effects.

  2006influential reference
• Protein structures in virtual screening: a case study with CDK2.

  2006cited by this paper
• A Comprehensive Structure-Based Alignment of Prokaryotic and Eukaryotic Neurotransmitter/Na+ Symporters (NSS) Aids in the Use of the LeuT Structure to Probe NSS Structure and Function

  2006cited by this paper
• Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants*

  2006cited by this paper
• The Discovery of Fluoxetine Hydrochloride (Prozac)

  2005cited by this paper
• Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes*

  2005influential reference
• Case history: the discovery of fluoxetine hydrochloride (Prozac).

  2005cited by this paper
• CH...O and CH...N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor.

  2005cited by this paper
• Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters

  2005cited by this paper
• Unveiling the full potential of flexible receptor docking using multiple crystallographic structures.

  2005cited by this paper
• Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.

  2005cited by this paper
• Structure and Function of Extracellular Loop 4 of the Serotonin Transporter as Revealed by Cysteine-scanning Mutagenesis*

  2004cited by this paper
• UniProt: the Universal Protein knowledgebase

  2004cited by this paper
• Identification of a Minimal Subset of Receptor Conformations for Improved Multiple Conformation Docking and Two-Step Scoring

  2004cited by this paper
• Nuclear hormone receptor targeted virtual screening.

  2003cited by this paper
• Synthesis and Molecular Modeling of New 1-Aryl-3-[4-arylpiperazin-1-yl]-1-propane Derivatives with High Affinity at the Serotonin Transporter and at 5-HT1A Receptors

  2002cited by this paper
• Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.

  2002cited by this paper
• Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding

  2002cited by this paper
• Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition.

  2001cited by this paper
• Improved scoring of ligand-protein interactions using OWFEG free energy grids.

  2001cited by this paper
• A Functional-Phylogenetic Classification System for Transmembrane Solute Transporters

  2000cited by this paper
• Transmembrane Domain I Contributes to the Permeation Pathway for Serotonin and Ions in the Serotonin Transporter

  1999cited by this paper
• High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis

  1998cited by this paper
• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  1997cited by this paper
• The Third Transmembrane Domain of the Serotonin Transporter Contains Residues Associated with Substrate and Cocaine Binding*

  1997cited by this paper
• Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.

  1994influential reference
• ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation

  1994cited by this paper
• Comparison of the predicted and observed secondary structure of T4 phage lysozyme.

  1975cited by this paper
• Simple Allosteric Model for Membrane Pumps

  1966cited by this paper

• NS-398-induced membrane stiffening as a biophysical factor affecting memory-related processes.

  2026cites this paper
• Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development

  2025cites this paper
• Deciphering the Antioxidant and Neuropharmacological Effects of Methanolic Extract of Artocarpus chama Leaves and Its n‐Hexane and Ethyl Acetate Fractions: GC–MS Analysis, Experimental, and In Silico Investigations

  2025cites this paper
• Design, synthesis and evaluation of 1-(1,5-bis(4-substituted phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors with potential antidepressant action.

  2023cites this paper
• Allosteric modulators of solute carrier function: a theoretical framework

  2023cites this paper
• Homology Modeling of Transporter Proteins.

  2023cites this paper
• In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters

  2022cites this paper
• Structure-based Discovery of Conformationally Selective Inhibitors of the Serotonin Transporter

  2022cites this paper
• Pharmacoprint - a combination of pharmacophore fingerprint and artificial intelligence as a tool for computer-aided drug design

  2021cites this paper
• Exploring the molecular mechanism of the effect of puerarin on P2X3.

  2020cites this paper
• The Serotonergic System

  2019cites this paper
• Prediction of 5-hydroxytryptamine transporter inhibitors based on machine learning

  2019cites this paper
• Allosteric modulation of GABAergic and glutamatergic metabotropic receptors

  2018cites this paper
• Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters.

  2018cites this paper
• Computational study of SERT using new X-ray crystal structures and initial experimental verification of potential GABAB receptor compounds

  2018cites this paper
• Diastereoselectivity of Azido-Ugi Reaction with Secondary Amines. Stereoselective Synthesis of Tetrazole Derivatives.

  2017cites this paper
• Structural basis for recognition of diverse antidepressants by the human serotonin transporter

  2017cites this paper
• Identification of novel serotonin reuptake inhibitors targeting central and allosteric binding sites: A virtual screening and molecular dynamics simulations study.

  2017cites this paper
• Modulatory actions of serotonergic system in cardiac function, behavior, and sensorimotor circuit activity in Drosophila melanogaster

  2016cites this paper
• DIPLOMARBEIT / DIPLOMA THESIS

  2016cites this paper
• Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study.

  2016cites this paper
• Novel Molecular Targets of Dezocine and Their Clinical Implications

  2014cites this paper
• Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters

  2014cites this paper
• Binding of Mazindol and Analogs to the Human Serotonin and Dopamine Transporters

  2014cites this paper
• Identification of Novel Serotonin Transporter Compounds by Virtual Screening

  2014cites this paper
• Structure, function and ligand interactions of the ecdysone receptor from Daphnia magna

  2014cites this paper
• Synthesis, Antidepressant Evaluation and Docking Studies of Long‐Chain Alkylnitroquipazines as Serotonin Transporter Inhibitors

  2013cites this paper
• Combining Structure‐Based Pharmacophore and In Silico Approaches to Discover Novel Selective Serotonin Reuptake Inhibitors

  2013cites this paper
• DOLINA - Docking Based on a Local Induced-Fit Algorithm: Application toward Small-Molecule Binding to Nuclear Receptors

  2013cites this paper
• Molecular Modelling and Docking Studies of Human Blood Coagulation Factor-XIIIA Protein

  2013cites this paper
• Interaction of Antidepressants with the Serotonin and Norepinephrine Transporters

  2012cites this paper
• 1,3-diaryl - substituted heterocyclic pesticides

  2012cites this paper
• Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.

  2012cites this paper